United Therapeutics Corporation (UTHR)

Quick ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash	US$ in thousands	1,207,700	1,107,700	1,067,300	1,163,500	961,200	966,800	795,200	813,300	894,800	908,500	942,200	832,300	738,700	670,200	685,400	875,200	738,400	719,700	881,300	790,600
Short-term investments	US$ in thousands	1,801,300	1,784,700	1,632,000	1,721,800	1,908,200	1,685,500	1,509,000	1,550,500	1,035,900	1,191,300	1,090,300	965,300	1,096,300	910,300	875,300	669,300	747,500	850,300	904,900	814,500
Receivables	US$ in thousands	278,900	258,600	272,700	134,500	220,400	231,700	173,400	170,500	198,700	212,800	173,400	141,100	157,400	152,300	172,000	149,600	151,400	183,600	181,000	159,800
Total current liabilities	US$ in thousands	804,400	744,100	370,300	324,600	343,200	315,900	331,500	292,600	305,400	320,000	311,400	302,400	323,300	258,900	255,000	207,300	463,000	469,900	463,500	270,000
Quick ratio		4.09	4.23	8.03	9.30	9.00	9.13	7.47	8.66	6.97	7.23	7.08	6.41	6.16	6.69	6.79	8.17	3.54	3.73	4.24	6.54

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,207,700K + $1,801,300K + $278,900K) ÷ $804,400K
= 4.09

The quick ratio of United Therapeutics Corp has shown relatively high and stable values over the past eight quarters. The quick ratio measures the company's ability to meet its short-term obligations using its most liquid assets. A quick ratio above 1 indicates that the company has enough liquid assets to cover its current liabilities.

In Q4 2023, the quick ratio was 4.28, which indicates that the company had $4.28 in liquid assets for every $1 of current liabilities. This was slightly lower compared to the previous quarter but still at a comfortable level.

Overall, the company's quick ratio has been consistently high, ranging from 4.28 to 9.55 over the past eight quarters. This suggests that United Therapeutics Corp has a strong ability to meet its short-term obligations using its liquid assets. A high quick ratio typically indicates good liquidity and financial health, providing assurance to investors and creditors regarding the company's ability to manage its short-term financial commitments.